Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice

Volume 2014 (2014), Article ID 415638, 7 pages
Research Article

Allergic Contact Dermatitis Is Associated with Significant Oxidative Stress

1Clinic of Dermatology, University of Tartu, 31 Raja Street, 50417 Tartu, Estonia

2Institute of Biomedicine and Translational Medicine, Department of Biochemistry, the Centre of Excellence for Translational Medicine, University of Tartu, 19 Ravila Street, 50411 Tartu, Estonia

3Institute of Computer Science, University of Tartu, 2 J. Liivi Street, 50409 Tartu, Estonia

Received 8 July 2014; Accepted 23 July 2014; Published 11 August 2014

Academic Editor: Masutaka Furue

Copyright © 2014 S. Kaur et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background. Research has confirmed the involvement of oxidative stress (OxS) in allergic contact dermatitis whilst other inflammation-related biomarkers have been less studied. Objective. To evaluate systemic levels of selected inflammatory markers, OxS indices and adipokines as well as their associations in allergic contact dermatitis. Methods. In 40 patients, interleukin- (IL-) 6, monocyte chemoattractant protein (MCP-1), and IL-10 levels were measured in sera with the Evidence Investigator Cytokine & Growth factors High-Sensitivity Array, total peroxide concentration (TPX) and total antioxidant capacity (TAC) by means of spectrophotometry, and the plasma concentrations of adiponectin and leptin by the quantitative sandwich enzyme immunoassay technique. Results. TNF-α level (P < 0.01) and TPX (P < 0.0001) were increased whilst IL-10 (P < 0.05) and TAC (P < 0.0001) were decreased in the patients as compared to controls. Correlation and multiple linear regression analysis identified both, TPX and TAC (inversely), as possible independent markers for evaluating allergic contact dermatitis. Adiponectin level in patients was increased (P < 0.0001), but neither adiponectin nor leptin correlated significantly with the biomarkers of inflammation or OxS. Conclusion. OxS parameters, especially TPX and OSI, reflect the degree of systemic inflammation associated with allergic contact dermatitis in the best way. The relation between OxS and adiponectin level warrants further studies.

1. Introduction

Inflammation and oxidative stress (OxS), the latter defined as an overproduction of reactive oxygen as well as nitrogen species (ROS and RSN, resp.) with concomitant deficiency of antioxidative defenses of the body [1, 2], have been found to be inextricably connected in physiological as well as disease states [1]. In allergic contact dermatitis, elevated systemic levels of interleukin- (IL-) 6, IL-1, and tumor necrosis factor (TNF)-α have been found [3, 4], and ROS are proposed to participate in the initial allergen sensitization as well as in the development of pathogenic allergic responses [5].

Both, OxS and inflammatory mediators such as cytokines and C-reactive protein (CRP) have an influence on the adipokine status [68]. Adiponectin, a cytokine produced solely by adipose tissue, possesses antidiabetic, antiatherogenic, and potent anti-inflammatory activities [9, 10]. In accordance with its anti-inflammatory character, adiponectin levels are increased, rather than decreased, in a number of chronic inflammatory and autoimmune diseases [11]. Inverse correlations of adiponectin with markers of OxS and inflammation have been previously found [7, 9, 12]. The second most important adipokine leptin is known primarily by its ability to regulate food intake and energy expenditure [13]. Leptin has predominantly proinflammatory functions [11], promoting, for example, the activation and production of oxidative burst of inflammatory cells [13].

The current study was undertaken to concurrently examine selective biomarkers of inflammation, OxS, and inflammation-related adipokines as well as their associations in patients with acute/subacute allergic contact dermatitis involving approximately 5% of body surface.

2. Methods

Patients for this study were recruited from the Clinic of Dermatology of Tartu University, Estonia. The study involved 40 patients (6 male, 34 female, age 23–67 years, mean age years, mean BMI  kg/m2) who came to our clinic for patch testing due to acute/subacute allergic contact dermatitis, confined mostly to their hands or face (23 and 11 patients, resp.). Blood from the patients’ antecubital vein was collected on the fifth day of routine patch testing after overnight fast. At the time of blood collection, 31 patients had one or more positive patch test results on their back, including 19 patients with positive patch test result to 5% nickel sulphate, nine to 0.01% methylisothiazolinone and eight patients to 1% formaldehyde. The remaining nine patients had given positive patch test results in a previous testing, and current dermatitis was associable with their contact allergy. All patients were tested with European standard series purchased from Hal Allergie GMBH, Düsseldorf, Germany, and allergens were applied on the skin with Finn Chambers on Scanpor (SmartPractice, Phoenix, USA). The patients were not treated with systemic corticosteroids at least for a month and any local corticosteroids were avoided for 24 hours before patch testing. The patients did not have active infections and concomitant chronic diseases as determined by the anamnesis, clinical assessment, and laboratory measurement of blood count, blood glucose level (>5.5 mmol/L), and total cholesterol (>6.9 mmol/L) at the time of recruitment. Collected blood samples were centrifuged at 1500 ×g for 10 min and the serum was divided into aliquots and stored at −70°C for subsequent analysis.

The results obtained from the patients were compared against the data of age-matched normal weight healthy subjects from the database of the Institute of Biochemistry of Tartu University. Cytokine levels were compared with a control group (Co) consisting of 40 healthy subjects (14 male, 26 female, age years, range 19–58 years, mean BMI  kg/m2), OxS parameters with the data of 40 healthy individuals (25 male, 15 female, age years, range 20–58 years, mean BMI  kg/m2), adiponectin level with its levels in 51 healthy subjects (19 male, 32 female, age years, range 21–53 years, mean BMI  kg/m2), and leptin level with the data of 20 healthy women (age years, range 20–60 years, mean BMI  kg/m2). The study was approved by the Ethics Committee of the Faculty of Medicine of the University of Tartuand conducted after obtaining a signed consent from each participant.

2.1. Measurement of Adiponectin, Leptin, and Cytokine Levels

The plasma concentrations of adiponectin and leptin were analyzed by a quantitative sandwich enzyme immunoassay technique, using commercially available kits (R&D Systems, Minneapolis, MN, USA).

IL-6, monocyte chemoattractant protein (MCP-1) and IL-10 levels were measured in sera with the Evidence Investigator Cytokine & Growth factors High-Sensitivity Array (CTK HS Cat. number EV 3623 RANDOX Laboratories Ltd., Crumlin, United Kingdom) according to the manufacturer’s protocol. Assay sensitivity varied from 0.12 pg/L to 2.12 pg/L, depending on the analyte. The reproducibility of the assay for an individual cytokine was determined using the quality controls provided with the kit.

HsCRP was analyzed by immunoturbimetry method at the Laboratory of Biochemistry of the Tartu University Hospital. The level of hsCRP 1.0 mg/L was used as a cut-off point to define a higher inflammatory status.

2.2. Measurement of Total Peroxide Concentration

Total peroxide concentration of samples was determined using OXYSTAT Assay Kit Cat. number BI-5007 (Biomedica Gruppe, Biomedica Medizinprodukte GmbH & Co Kg, Wien). The kit detects peroxide concentrations based on the reaction of biological peroxides with peroxidase and a subsequent color-reaction using tetramethylbenzidine (TMB) as substrate. The colored liquid is measured photometrically at 450 nm, using ELISA plate reader Photometer Sunrise (Tecan Austria GmbH, Salzburg). The concentration is stated as H2O2-equivalents (μmol/L).

2.3. Assessment of Total Antioxidant Capacity

The basic principle of the method is that a colourless molecule, reduced 2,2-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS), is oxidized to a characteristic blue-green ABTS, using hydrogen peroxide in acidic medium (the acetate buffer 30 mml/L pH 3,6) [14]. When the coloured ABTS is mixed with any substance, that can be oxidized, it is reduced to its original colourless ABTS form again. The ABTS is decolorized by antioxidants according to their concentrations and antioxidant capacities. This change in colour is measured as a change in absorbance at 660 nm. The reaction rate was calibrated with Trolox. The results are expressed in mmol Trolox equivalent/L. Within- and between-batch precision data obtained by TAC method were 2.5% and 2.9%, respectively.

2.4. Oxidative Stress Index

Percent ratio of the total peroxide concentration of plasma or other biological fluids (TPX) to the total antioxidant capacity of plasma or other biological fluids (TAC) is accepted as oxidative stress index (OSI), an indicator of the degree of oxidative stress [15]. According to this, we calculated OSI as the ratio of TPX (µmol/L) to TAC (µmol Trolox equivalent/L) × 100.

2.5. Statistical Analysis

Statistical analysis was performed using SAS 9.2 (SAS Institute Inc. NC, Cary, USA). All data are presented as mean standard deviation, and statistical significance was established as . A comparison between variables was assessed by the independent sample -test. Correlations between parameters were assessed using bivariate correlation analysis (Pearson correlation coefficient) and multiple regression analysis.

3. Results

3.1. Inflammatory and OxS Markers in Patients and Healthy Subjects

As shown in Table 1, the patients had significantly increased TNF-α serum levels whilst the increase in MCP-1 remained below the threshold of statistical significance ( and , resp.). IL-10 levels in the patients were decreased (; Table 1). The mean concentration of hsCRP in the patients was  mg/L, that is, not significantly different from the generally accepted maximum borderline value 1.0 mg/L.

Table 1: The levels of inflammatory markers and oxidative stress characteristics in the patients with acute/subacute allergic contact dermatitis covering approximately 5% of body surface as compared to healthy controls.

The most noticeable differences between the patients and Co were established in OxS markers levels: TPX in the patients was significantly increased while TAC was decreased ( in both) (Table 1). OSI, the percent ratio of TPX to TAC, was also significantly increased in the patients ().

3.2. The Relations between Markers of Inflammation and OxS

To confirm the possibility that inflammatory status is related to the diagnosis of allergic contact dermatitis, Pearson correlation coefficients were calculated, using combined patients’ and Co data from Table 1. Significant positive correlations with the diagnosis of allergic contact dermatitis were found for TNF-α (, ), MCP-1 (, ), TPX (, ), and OSI (, ), and negative correlations for IL-10 (, ), and TAC (, ). Further multiple linear regression analysis starting with all covariates, for example, age, gender, BMI, TPX, TAC, and OSI also, revealed significant positive correlation of the diagnosis of allergic contact dermatitis with TPX (, ) and inverse correlation with TAC level (, ).

We further analyzed the correlations between markers of inflammation and OxS in the group of patients and established relevant positive correlations between MCP-1 and IL-6 levels (, Figure 1(a)) as well as between hsCRP and OSI (; Figure 1(b)).

Figure 1: Correlations between inflammatory and oxidative stress markers in patients with acute/subacute allergic contact dermatitis approximately on 5% of body surface. MCP: monocyte chemoattractant protein; IL: interleukin; OSI: oxidative stress index; hsCRP: high sensitive C-reactive protein; TNF: tumor necrosis factor; TAC: total antioxidant capacity; TE: Trolox equivalent; TPX: total peroxide concentration.

TNF-α level, which was most significantly increased in the patients, correlated neither with other inflammatory markers nor the indices of OxS. Both MCP-1 and IL-6 correlated positively with patients’ BMI (, and , resp., Table 2). Therefore, we continued to follow the relationship between inflammatory markers and BMI, including the analysis the patients and a corresponding Co. As shown in Table 2, subjects’ BMI was positively correlated with the age () and inflammatory markers IL-6 and MCP-1 (, and , resp., Figures 2(a) and 2(b)). At the same time, BMI was not correlated to the OxS markers in the patients and Co analyzed together (Table 2, Figures 2(c) and 2(d)). Correlation coefficients between age/TPX and age/TAC were also insignificant (−0.059, and 0.034, resp.).

Table 2: Correlations between inflammatory and oxidative stress markers and their correlations with subjects’ age and BMI in patients with allergic contact dermatitis and healthy controls.
Figure 2: Scatterplot of correlation analysis of IL-6, MCP-1, TPX, and TAC with BMI in patients with allergic contact dermatitis and healthy controls. IL: interleukin; MCP: monocyte chemoattractant protein; TPX: total peroxide concentration; TAC: total antioxidant capacity; TE: Trolox equivalent; BMI: body mass index.

Other significant relations in patients and Co analyzed as whole were strong positive correlations between IL-6 and MCP-1, as well as inverse correlation between TPX and TAC (Table 2).

3.3. Adiponectin and Leptin Levels and Their Associations with the Biomarkers of Inflammation and OxS

Plasma concentration of adiponectin was significantly higher in the patients, compared with the mean value of 51 healthy normal weight controls with no statistically significant differences according to their age and gender ( ng/mL and  ng/mL, ). The levels of plasma adiponectin in the patients were inversely but nonsignificantly related to the BMI (, ). We found no correlations of adiponectin level with any markers of inflammation or OxS in the patients except an inverse correlation between adiponectin and TPX (, ) that, however, was only close to statistically significant relationship.

As leptin level in women exceeds the values in men two-three times [16] and our sample was predominantly female (85.0%), we calculated the mean leptin level in 34 female patients and compared it to the level in 20 female Co. The obtained values were significantly different ( pg/mL, and  pg/mL, resp., ). On the other hand, blood leptin level positively correlates with body weight [9, 11]. With the adjustment for BMI, which was different in our patients and Co ( kg/m2, and  kg/m2, ), the difference in leptin levels between female patients and Co became insignificant. The correlation of leptin level with BMI had only borderline significance (, ) when analyzed in the patients and Co as whole (). There were no significant correlations between leptin levels and biomarkers of inflammation and OxS.

4. Discussion

The most remarkable finding of this study was that acute/subacute skin inflammation consisting of inflammatory lesions on the face or hands and positive patch test reaction site on the patients’ back brought about considerable OxS.

Earlier studies have documented the rise in serum levels of several proinflammatory factors after exposure to contact allergens. The increase of TNF-α and, to some extent, MCP-1 levels in our patients is in concordance with the results obtained in patients with parthenium dermatitis [17] and trichloroethylene-induced hypersensitivity [18] and might be explained by the activities of activated T cells [19]. In case of inflammation, TNF-α, which is present in healthy skin, is additionally synthesized by activated macrophages, T cells, and keratinocytes and released into circulation [19]. Furthermore, contact allergens and irritants can directly induce the expression of both TNF-α and MCP-1 [20]. For example, Martín et al. (2003) have demonstrated the expression of MCP-1 by basal keratinocytes and isolated dermal cells at 10 hours after antigen challenge, paralleled by dermal accumulation of mononuclear cells [21]. TNF-α stimulates the production of several other cyto- and chemokines, including MCP-1, by fibroblasts, endothelial cells, macrophages, and dendritic cells [21].

Though allergic contact dermatitis has been mainly associated with Th1/Th17 phenotypes, Th2-type regulatory cytokines such as IL-10 may have an important role in the downregulation of contact hypersensitivity reactions [3]. Therefore, decreased IL-10 concentrations, found in this and some previous studies [17, 22], might indicate the utilization of this cytokine in downregulation of allergic contact dermatitis.

Several inflammatory markers, including TNF-α and MCP-1, have been correlated with body weight [11, 23]. We found similar correlations for MCP-1 and IL-6; this demonstrates the decrease of their importance as markers of the activity of the inflammation in allergic contact dermatitis. At the same time, OxS parameters did not depend on patients’ BMI.

The measurement of TPX and TAC has been currently effectively used to characterize both sides of OxS compendiously, including several conditions not related to infections or inflammation, for example, white-coat hypertension [24] and major depression [25]. In addition, the ratio of TPX to TAC (OSI) gives a single numerical value to evaluate the degree of OxS [15]. Our study of patients with restricted allergic contact dermatitis demonstrated a significant increase in the oxidants pool and decrease in antioxidative capacity; the latter can be explained by the consumption of radical-scavenging antioxidants due to increased free radical amounts [15]. The prevalence of OxS indices over inflammatory is in agreement with the concept that OxS may be the starter point in the pathogenesis of allergic contact dermatitis, leading to the activation of transcription factors and signaling pathways and further synthesis of inflammatory cytokines [4, 5]. Some recent studies have confirmed the ability of contact allergens to induce OxS pathway in keratinocytes [26, 27]. Our own previous study showed the decrease in antioxidants pool of the skin, evidenced by increased oxidized glutathione/reduced glutathione ratio in positive to 5% nickel sulphate patch test site [28]. The presence of contact allergen-related OxS was also confirmed by Gangemi et al. (2009) who found increased serum concentrations of nitrosylated proteins (biomarkers of OxS) in nickel-allergic female patients after oral nickel challenge [29]. Considering all the above-mentioned facts, TPX may be the best and earliest marker of systemic changes occurring in the body after allergen challenge and before the visible inflammation. This marker could be used in the evaluation of treatment results when developing new anti-inflammatory drugs or cosmetic products.

Adiponectin and leptin, the most abundant products of the adipose tissue, have considerable effects on metabolic, inflammatory, and immune responses [16]. Well-recognized activities of adiponectin include the induction of anti-inflammatory mediators such as IL-10 and IL-1 receptor antagonist and inhibition of TNF-α and NF-κB on endothelial cells [30]. The levels of adiponectin have been found to be inversely associated with marker of inflammation CRP in patients with diabetes [9] and coronary atherosclerosis [31]. However, no evidence suggests an association between plasma adiponectin and TNF-α in humans [32].

The relationship between adiponectin and OxS is likewise very complex. In general, low levels of adiponectin are associated with increased OxS [8], and some studies have concluded that adiponectin exerts its antiatherogenic and antidiabetic effects through the modulation of OxS [6]. In addition, higher levels of adiponectin are associated with more beneficial OxS profile in elderly population [12]. At the same time, positive as well as inverse correlations have been found between markers of OxS (isoprostanes) and adiponectin [6, 7]. An explanation for elevation of adiponectin in our allergic contact dermatitis patients may be that adiponectin represents a beneficial counter regulatory response to reduce oxidative burden similarly as it has been concluded in type 1 diabetes mellitus [8]. There was an inverse correlation between adiponectin and TPX, however, with the value below the statistical significance (). Regardless of that, these results suggest the possibility that the increase of adiponectin level may be compensatory, evoked by high TPX concentration.

Leptin that is functionally and structurally related to proinflammatory cytokines [33] polarizes T cells towards a cell phenotype [11] while promoting monocyte recruitment and secretion of proinflammatory cytokines [33]. Thus, there are several mechanisms by which leptin could lead to greater inflammation. As women have markedly higher leptin concentrations as compared to men, even when adjusted for BMI [34], we investigated leptin levels only in female patients, comparing it to the value in female Co. After adjustment for BMI, we did not find differences in serum leptin levels between the patients and Co. There were no significant correlations between leptin levels and biomarkers of inflammation or OxS. Therefore, inclusion of adiponectin and leptin in severity assessment of allergic contact dermatitis may not be clinically useful.

In conclusion, the systemic effect of allergic contact dermatitis was most conspicuous in the parameters of OxS especially in TPX and OSI levels. The level of adiponectin was increased and showed a tendency to correlate inversely with TPX concentration. Therefore, as compared to inflammatory markers and adipokine levels, OxS parameters might be most helpful to assess disease activity and therapeutic response in allergic contact dermatitis.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


The study was supported by the Estonian Science Foundation Grant no. 7549 and by targeted financing from the Ministry of Education and Science of Estonia (SF0180105s08 and SF0180043S07).


  1. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Nakai, K. Yoneda, and Y. Kubota, “Oxidative stress in allergic and irritant dermatitis: from basic research to clinical management,” Recent Patents on Inflammation & Allergy Drug Discovery, vol. 6, no. 3, pp. 202–209, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Cavani, O. De Pità, and G. Girolomoni, “New aspects of the molecular basis of contact allergy,” Current Opinion in Allergy and Clinical Immunology, vol. 7, no. 5, pp. 404–408, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Albanesi, “Keratinocytes in allergic skin diseases,” Current Opinion in Allergy and Clinical Immunology, vol. 10, no. 5, pp. 452–456, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Corsini, V. Galbiati, D. Nikitovic, and A. M. Tsatsakis, “Role of oxidative stress in chemical allergens induced skin cells activation,” Food and Chemical Toxicology, vol. 61, pp. 74–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Nakanishi, K. Yamane, N. Kamei, H. Nojima, M. Okubo, and N. Kohno, “A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane,” Metabolism: Clinical and Experimental, vol. 54, no. 2, pp. 194–199, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Katsuki, M. Suematsu, E. C. Gabazza et al., “Increased oxidative stress is associated with decreased circulating levels of adiponectin in Japanese metabolically obese, normal-weight men with normal glucose tolerance,” Diabetes Research and Clinical Practice, vol. 73, no. 3, pp. 310–314, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. L. Prior, T. S. Tang, G. V. Gill, S. C. Bain, and J. W. Stephens, “Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk “golden Years” type 1 diabetes mellitus cohort,” Metabolism: Clinical and Experimental, vol. 60, no. 2, pp. 173–179, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. G. K. Shetty, P. A. Economides, E. S. Horton, C. S. Mantzoros, and A. Veves, “Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes,” Diabetes Care, vol. 27, no. 10, pp. 2450–2457, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. D. K. Oh, T. Ciaraldi, and R. R. Henry, “Adiponectin in health and disease,” Diabetes, Obesity and Metabolism, vol. 9, no. 3, pp. 282–289, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Ouchi, J. L. Parker, J. J. Lugus, and K. Walsh, “Adipokines in inflammation and metabolic disease,” Nature Reviews Immunology, vol. 11, no. 2, pp. 85–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Gustafsson, L. Lind, S. Söderberg, M. Zilmer, J. Hulthe, and E. Ingelsson, “Oxidative stress and inflammatory markers in relation to circulating levels of adiponectin,” Obesity, vol. 21, no. 7, pp. 1467–1473, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Lago, C. Dieguez, J. Gómez-Reino, and O. Gualillo, “The emerging role of adipokines as mediators of inflammation and immune responses,” Cytokine and Growth Factor Reviews, vol. 18, no. 3-4, pp. 313–325, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Erel, “A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation,” Clinical Biochemistry, vol. 37, no. 4, pp. 277–285, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Serefhanoglu, A. Taskin, H. Turan, F. E. Timurkaynak, H. Arslan, and O. Erel, “Evaluation of oxidative status in patients with brucellosis,” Brazilian Journal of Infectious Diseases, vol. 13, no. 4, pp. 249–251, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Tilg and A. R. Moschen, “Adipocytokines: mediators linking adipose tissue, inflammation and immunity,” Nature Reviews Immunology, vol. 6, no. 10, pp. 772–783, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Akhtar, K. K. Verma, and A. Sharma, “Study of pro-and anti-inflammatory cytokine profile in the patients with parthenium dermatitis,” Contact Dermatitis, vol. 63, no. 4, pp. 203–208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. Q. Jia, D. Zang, J. Yi et al., “Cytokine expression in trichloroethylene-induced hypersensitivity dermatitis: an in vivo and in vitro study,” Toxicology Letters, vol. 215, no. 1, pp. 31–39, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Kerstan, E.-B. Bröcker, and A. Trautmann, “Decisive role of tumor necrosis factor-α for spongiosis formation in acute eczematous dermatitis,” Archives of Dermatological Research, vol. 303, no. 9, pp. 651–658, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Kerstan, M. Leverkus, and A. Trautmann, “Effector pathways during eczematous dermatitis: where inflammation meets cell death,” Experimental Dermatology, vol. 18, no. 10, pp. 893–899, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. P. Martín, J. Gagliardi, C. E. Baena-Cagnani et al., “Expression of CS-1 fibronectin precedes monocyte chemoattractant protein-1 production during elicitation of allergic contact dermatitis,” Clinical and Experimental Allergy, vol. 33, no. 8, pp. 1118–1124, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Kaur, K. Zilmer, V. Leping, and M. Zilmer, “Comparative study of systemic inflammatory responses in psoriasis vulgaris and mild to moderate allergic contact dermatitis,” Dermatology, vol. 225, no. 1, pp. 54–61, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Christiansen, B. Richelsen, and J. M. Bruun, “Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects,” International Journal of Obesity, vol. 29, no. 1, pp. 146–150, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Yildiz, M. Gür, R. Yilmaz et al., “Lymphocyte DMA damage and total antioxidant status in patients with white-coat hypertension and sustained hypertension,” Archives of the Turkish Society of Cardiology, vol. 36, no. 4, pp. 231–238, 2008. View at Google Scholar · View at Scopus
  25. M. Maes, I. Mihaylova, M. Kubera, M. Uytterhoeven, N. Vrydags, and E. Bosmans, “Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease,” Journal of Affective Disorders, vol. 125, no. 1–3, pp. 287–294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. R. J. Vandebriel, J. L. A. Pennings, K. A. Baken et al., “Keratinocyte gene expression profiles discriminate sensitizing and irritating compounds,” Toxicological Sciences, vol. 117, no. 1, pp. 81–89, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. D. H. Kim, D. Byamba, W. H. Wu, T. Kim, and M. Lee, “Different characteristics of reactive oxygen species production by human keratinocyte cell line cells in response to allergens and irritants,” Experimental Dermatology, vol. 21, no. 2, pp. 99–103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Kaur, M. Zilmer, M. Eisen et al., “Nickel sulphate and epoxy resin: differences in iron status and glutathione redox ratio at the time of patch testing,” Archives of Dermatological Research, vol. 295, no. 12, pp. 517–520, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Gangemi, L. Ricciardi, P. L. Minciullo et al., “Serum levels of protein oxidation products in patients with nickel allergy,” Allergy and Asthma Proceedings, vol. 30, no. 5, pp. 552–557, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Tilg, “Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis,” Current Pharmaceutical Design, vol. 16, no. 17, pp. 1893–1894, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Ouchi, S. Kihara, T. Funahashi et al., “Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue,” Circulation, vol. 107, no. 5, pp. 671–674, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Ouchi and K. Walsh, “Adiponectin as an anti-inflammatory factor,” Clinica Chimica Acta, vol. 380, no. 1-2, pp. 24–30, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S. S. Martin, A. N. Qasim, D. J. Rader, and M. P. Reilly, “C-reactive protein modifies the association of plasma leptin with coronary calcium in asymptomatic overweight individuals,” Obesity, vol. 20, no. 4, pp. 856–861, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Lago, R. Gómez, J. J. Gómez-Reino, C. Dieguez, and O. Gualillo, “Adipokines as novel modulators of lipid metabolism,” Trends in Biochemical Sciences, vol. 34, no. 10, pp. 500–510, 2009. View at Publisher · View at Google Scholar · View at Scopus